BlackRock Investment Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $2.54M | Buy |
41,857
+7,219
| +21% | +$438K | ﹤0.01% | 2059 |
|
2016
Q3 | $2.3M | Buy |
34,638
+1,164
| +3% | +$77.2K | ﹤0.01% | 2041 |
|
2016
Q2 | $1.87M | Buy |
33,474
+1,798
| +6% | +$100K | ﹤0.01% | 2156 |
|
2016
Q1 | $1.07M | Buy |
31,676
+102
| +0.3% | +$3.43K | ﹤0.01% | 2438 |
|
2015
Q4 | $1.43M | Buy |
31,574
+414
| +1% | +$18.7K | ﹤0.01% | 2323 |
|
2015
Q3 | $1.23M | Sell |
31,160
-517
| -2% | -$20.4K | ﹤0.01% | 2446 |
|
2015
Q2 | $1.97M | Buy |
31,677
+7,138
| +29% | +$443K | ﹤0.01% | 2248 |
|
2015
Q1 | $1.54M | Buy |
24,539
+4,891
| +25% | +$306K | ﹤0.01% | 2214 |
|
2014
Q4 | $1.11M | Sell |
19,648
-353
| -2% | -$19.9K | ﹤0.01% | 2478 |
|
2014
Q3 | $566K | Buy |
20,001
+234
| +1% | +$6.62K | ﹤0.01% | 2893 |
|
2014
Q2 | $681K | Buy |
+19,767
| New | +$681K | ﹤0.01% | 2851 |
|